Amniotic Membrane Market, By Product Type (Amniotic Membranes (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes), Amniotic Suspensions) By Application (Wound Care, Orthopedics, Ophthalmology, Others), By End User (Hospital, Ambulatory Surgical Centers, Specialty Clinics, Research and Academic Institutes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
On September 13, 2021, MiMedx Group, Inc., a biomedical company, reported data from two late-stage musculoskeletal trials with proprietary amniotic tissue technology.
On May 19, 2021, VIVEX Biologics, Inc., a regenerative medicine company, announced the launch of VIAGENEX, a family of amniotic allografts processed to retain the inherent mechanical properties of amniotic tissue and a rich supply of extracellular matrix, growth factors, and cytokines.